Novo Nordisk’s Ozempic wins FDA approval for chronic kidney disease

Ozempic’s Breakthrough in Chronic Kidney Disease Treatment The Food and Drug Administration (FDA) has approved Novo Nordisk’s Ozempic, a GLP-1 receptor agonist, for chronic kidney disease prevention in adults with Type 2 diabetes. This means Ozempic can now be used to prevent kidney disease from worsening, reducing kidney failure, and lowering the risk of cardiovascular … Read more

Trump health care plan likely good for pharmaceutical companies

Healthcare Under the Trump Administration: What to Expect Revamping Drug Pricing Strategies As the Trump administration takes office, pharmaceutical companies anticipate shifts in drug pricing policies. Unlike the hardline approach of the Biden administration, Trump may prioritize cost-cutting by targeting pharmacy benefit managers (PBMs) rather than directly implementing price controls on drugs. This change could … Read more